We investigate the role of methionine aminopeptidase 2 (MAP2) in miltefosine induced programmed cell death (PCD) in promastigote form of L. donovani. We report that TNP-470, an inhibitor of MAP2, inhibits programmed cell death in miltefosine treated promastigotes. It inhibits the biochemical features of metazoan apoptosis, including caspase3/7 protease like activity, oligonucleosomal DNA fragmentation, collapse of mitochondrial transmembrane potential, and increase in cytosolic pool of calcium ions but did not prevent the cell death and phosphatidyl serine externalization. The data suggests that the MAP2 is involved in the regulation of PCD in parasite. Moreover, TNP-470 shows the leishmanicidal activity (IC 50 = 15 µM) and in vitro inhibition of LdMAP2 activity (K i = 13.5 nM). Further studies on MAP2 and identification of death signaling pathways provide valuable information that could be exploited to understand the role of non caspase proteases in PCD of L. donovani.
MAP2 selectively without inhibiting closely related isoenzyme MAP1 30 . However, the functional role(s) of MAP2 in protozoan parasite Leishmania is not very well explored.
In the present study, we cloned, expressed, purified and characterized MAP2. Further, we confirmed inhibition of MAP2 from L. donovani (LdMAP2) by TNP-470 and derived biochemical parameters of inhibition. We have successfully demonstrated that a specific MAP2 inhibitor prevents miltefosine induced apoptotic features like increased caspase3/7 protease like activity, DNA degradation, disruption in transmembrane potential of mitochondria, and increase in cytosolic calcium.
Results
Cloning, Expression, Purification and Biochemical characterization of LdMAP2. Various steps of cloning, expression and purification of LdMAP2 are shown in (Fig. S1 ). The genomic DNA of L. donovani was amplified using gene specific primers of LdMAP2. The amplified band of 1.39 kb was cloned in pET-28a(+) vector as described in methods section. The pET-28a(+)-LdMAP2 construct was confirmed by PCR and restriction digestion. The PCR amplification of 1.39 kb band and release of 1.39 kb band by double digestion with EcoRI and XhoI, confirmed the insertion of LdMAP2 in pET-28a(+) vector (Fig. S1 ). The clone was further confirmed by sequencing using primers for T7 promoter and T7 terminator.
The pET-28a(+)-LdMAP2 construct was transformed into BL21 (DE3) expression strain of E. coli, induced by 250 μM final concentration of IPTG (25 °C, 8 hrs) for the overexpression of protein and produced an insoluble and enzymatically inactive protein in inclusion bodies. The recombinant protein from inclusion bodies was solubilized in 8 M urea and purified by Ni-NTA affinity chromatography. The purified protein was dialyzed, refolded using the refolding buffer system as described in the methods section, and run on SDS-PAGE gel. Migration of LdMAP2 on SDS-PAGE showed an apparent molecular mass of 55.1 kDa (Fig. S1 ). Western blot analysis using mouse anti-His antibodies recognized the recombinant LdMAP2 containing His-tag at its N-terminal (Fig. S1 ). The approximate yield of recombinant LdMAP2 protein was 5 to 7 mg/L. The LdMAP2 enzymatic assay was carried out by measuring the release of 7-AMC by fluorescence at an excitation and emission wavelength of 360 nm and 440 nm, respectively. A pH range (pH 4.0 to 10.0) in mixed buffer system as mentioned in the methods section was used to determine the optimum pH for the enzyme activity against the fluorogenic substrate Methionine-7-amido-4-methyl coumarin (Met-AMC). The temperature range (20 °C to 60 °C) was used to check the optimum temperature. The pH and temperature optima studies showed an optimum pH of 7.5 and temperature optima at 37 °C for the substrate Met-AMC (Fig. S2 ). The activity of purified LdMAP2 was reduced to ~5% after incubating with 5 mM EDTA, signifying that metal ions are required for enzyme activity. The activity was found to be maximum in the presence of Ni(II), followed by Cu(II), Ca(II), Mg(II), Zn(II) and Mn(II). Furthermore, no LdMAP2 activity was observed in the absence of divalent metal ions (Fig. S2) . The enzyme kinetic studies showed the Km and Vmax values of 0.2 mM and 5.71 nM/min, respectively (Fig. 1A) . The Km and Vmax values were calculated by varying the substrate concentration of Met-AMC (10 µM to 100 µM).
Inhibition studies of functionally active LdMAP2 by TNP-470 and leishmanicidal activity of the inhibitor on L. donovani promastigotes. The inhibitor TNP-470 was found to inhibit LdMAP2 activity, which was assessed by Lineweaver-Burk plots (Fig. 1A ). TNP-470 showed a competitive mode of inhibition at a final concentration of 100 µM with respect to varied concentration of Met-AMC as Vmax did not change but there was an increase in Km value in the presence of inhibitor. The inhibitory constant (Ki) value was found to be 13.5 nM as the substrate concentration was varied. Inhibition studies for TNP-470 (100 µM), Competitive inhibition with respect to Met-AMC as a substrate. Ki value was found to be 13.5 nM. (B) MTT Assay; Effect of TNP-470 on L. donovani promastigotes, IC 50 value against L. donovani promastigotes were found to be 15.01 ± 0.73 µM. Data represents the mean ± SD of three independent experiments. Statistical analysis was done using Student's unpaired t-test in SigmaPlot software (*denotes p value ≤ 0.05 and **denotes p value < 0.01).
Scientific RepoRts | 7: 95 | DOI:10.1038/s41598-017-00186-9 L. donovani promastigote cells (2.5 × 10 6 cells/mL) were treated with varying concentrations (0.25 µM to 50 µM) of TNP-470 for 24 h to check the antileishmanial activity. TNP-470 showed significant leishmanicidal activity with IC 50 values of 15.01 ± 0.73 µM ( Fig. 1B) . Promastigote cells treated with 0.2% DMSO were used as negative control whereas cells treated with 25 µM of miltefosine served as positive control.
TNP-470 causes inhibition of Caspase3/7 protease like activity and oligonucleosomal-DNA fragmentation in L. donovani. Treatment of L. donovani promastigotes with miltefosine strongly revealed the apoptosis like mode of cell death with activation of Cas3/7 protease like activity which is well documented by various groups 31, 32 . In control studies, promastigote cells treated with miltefosine (25 µM for 18 h incubation at 25 °C) also showed an increased Cas3/7 protease like activity whereas the promastigote cells treated with TNP-470 (20 µM for 18 h incubation at 25 °C) did not show activation of Cas3/7 protease like activity. Unlike miltefosine treated cells, no significant increase in activity of Cas3/7 like protease was observed in case of promastigotes treated with both miltefosine (25 µM, 18 h) and TNP-470 (20 µM, 18 h). Cas3/7 protease like activity in cell lysates of miltefosine (25 µM) treated cells in presence of 100 µM of caspase-3 inhibitor (N-Acetyl-Asp-Glu-Val-Asp-al) or in presence of TNP-470 (20 µM) was even lesser than control cells ( Fig. 2 ). Control cells treated with 0.2% DMSO did not show significant increase in Cas3/7 protease like activity.
Flow cytometric analysis of promastigotes population was used to calculate the percentage of sub-G 1 cells (hypo-diploid cells) after cell permeabilization and staining with propidium-iodide (PI). The fluorescence intensity of bound PI correlates the amount of DNA in which the percentage of sub-G 1 peak shows the amount of DNA degradation in apoptotic like cells. Only 1.72% of the control cells (promastigote cells treated with 0.2% DMSO) were found in the sub-G 1 region (Fig. 3A) whereas leishmanial cells treated with 25 µM of miltefosine for 12 h resulted in 21.48% cells in apoptotic region (sub-G 1 peak region) ( Fig. 3B ). In contrast, no sub-G 1 peak region was found in TNP-470 (20 µM for 12 h) treated promastigote cells ( Fig. 3C ). Promastigote cells treated with both miltefosine and TNP-470 for 12 h resulted in only 4.85% cells in sub-G 1 peak region ( Fig. 3D ), thus suggesting that MAP2 inhibitors prevents the induction of nuclear apoptosis like features in L. donovani.
Fragmentation of genomic DNA into nucleosomal units is considered as the characteristic feature of apoptotic cell death 33 . DNA fragmentation analysis of promastigotes treated with miltefosine (25 µM), showed fragmentation of genomic DNA on agarose gel electrophoresis as reported earlier 31, 32 . No significant fragmentation of genomic DNA on agarose gel electrophoresis was observed in promastigote cells treated with TNP-470 (20 µM) and in control cells treated with 0.2% DMSO. Interestingly, the promastigote cells treated with both miltefosine (25 µM) and TNP-470 (20 µM) for 18 h did not show fragmentation of genomic DNA into oligonucleosomal fragments, suggesting the inhibition of DNA fragmentation in miltefosine mediated PCD ( Fig. 3E ).
TNP-470 treatment of L. donovani promastigotes does not inhibit the phosphatidyl serine externalization.
In higher eukaryotes, cells undergoing apoptosis are characterized by translocation of phosphatidyl serine from the inner side to outer layer of plasma membrane, which can be analyzed by flow cytometry using annexin V-FITC and PI 34 . Miltefosine is well known antileishmanial compound which causes translocation of phosphatidyl serine on outer plasma membrane in case of Leishmania promastigotes 31, 32 . A combined use of annexin V-FITC and PI was done to distinguish the apoptotic and necrotic cell death. Annexin V-FITC binds to exposed phosphatidyl serine with high affinity whereas PI selectively enters inside the necrotic cells and binds to DNA which allows the detection of both apoptotic and necrotic cells. Promastigotes treated with 25 µM of miltefosine for 18 h resulted in 51.71% of Annexin-V positive (Fig. 4B) , whereas cells treated with 20 µM TNP-470 for 18 h resulted in 21.9% of Annexin-V positive (Fig. 4C ). Only 1.06% annexin-V positive cells were present in control promastigotes treated with 0.2% DMSO for 18 h. When the cells were treated with both miltefosine (25 µM) and TNP-470 (20 µM), the Annexin-V positive cells were 76.3% ( Fig. 4) . Thus, the MAP2 inhibitor along with miltefosine shows cumulative effect for the externalization of phosphatidyl serine on plasma membrane in L. donovani promastigotes. TNP-470 prevents alteration of transmembrane potential of mitochondria (ΔΨm) caused by miltefosine. The depolarization of ΔΨm is the characteristic feature of apoptosis, observed in eukaryotic cells 33 . Change in mitochondrial membrane potential was detected by MitoCapture TM apoptosis detection kit, which is a cationic dye that aggregates in healthy mitochondria giving bright red fluorescence, but at lower membrane potential the dye remains in cytoplasm as monomers that fluoresce green. The mitochondrial membrane potential of promastigotes was examined by confocal microscopy stained by MitoCapture TM dye. Cells were treated with miltefosine and TNP-470, alone or both for 6 hr, mounted on glass-slides and images were captured. As shown in Fig. 5 , miltefosine treated cells showed an increase in green fluorescence ( Fig. 5B) whereas the TNP-470 treated cells showed an increase in red fluorescence (Fig. 5C ). The promastigote cells treated with both miltefosine and TNP-470, showed a significant increase in red fluorescence indicating the role of TNP-470 in the prevention of mitochondrial membrane damage in apoptotic like conditions. Leishmanial cells treated with both miltefosine (25 µM) and TNP-470 (20 µM) for 18 hr incubation at 25 °C, showed maximum debris on glass slides and were not suitable for imaging. Moreover, 6 h time point for mitochondrial membrane potential assay was chosen after optimization and based on earlier report 35 .
TNP-470 prevents increase in cytosolic calcium caused by miltefosine. Change in ΔΨm in apop-
totic like cell death of parasite results in release of cytochrome C from the mitochondria which in turn enhances the release of calcium from the endoplasmic reticulum, and causes a global increase in cytoplasmic calcium concentration inside the parasite. The increase in cytosolic calcium concentration in miltefosine treated cells was reported by several groups 36, 37 . In our studies, the measured fluorescence intensity at 510 nm was found to be maximum in promastigote cells treated with 25 µM of miltefosine for 18 h (Fig. 6 ). When cells were treated with both miltefosine (25 µM) and TNP-470 (20 µM) for 18 h, the total cytoplasmic calcium concentration was decreased compared to miltefosine treated cells. The diminished calcium concentration pool after treatment of TNP-470 signifies the retention of ΔΨm as mentioned in above section.
Discussion
Miltefosine treated L. donovani promastigotes shows the characteristic feature of metazoan apoptosis as reported earlier 31, 32 . Several other molecules i.e H 2 O 2 1 , heat shock 38 , staurosporine 39 etc. are also known to induce PCD in Leishmania promastigotes 40 . However, the biochemical pathways responsible for apoptosis like mode of cell death in Leishmania are still not fully deciphered. In mammalian cells, the proteolytic activation of caspases is essential for the induction of apoptosis 6, 7, 41 . The activation of caspases is also required for the execution of apoptosis in the invertebrates such as D. melanogaster 42 and C. elegans 43 . Even though the PCD was initially considered in multicellular organisms only, several reports suggested the similar biochemical features of PCD in unicellular eukaryotes such as T. thermophylia 44 , D. discoideum 45 , T. brucei 46 , T. cruzi 47 , L. major 40 , L. amazonensis 38 and L. donovani 4, 31 .
It is reported that broad caspase inhibitors (BAF) or calpain/cysteine protease inhibitors (E64) prevent the staurosporine induced PCD of Leishmania parasite but does not prevent the cell death 40 . Recently, it was reported that the cathepsin B like proteases are involved in PCD of parasite, and are capable to cleave caspase specific substrates 48 . Moreover, calpain inhibitor I was reported to prevent DNA fragmentation more efficiently which can inhibit calpain, cathepsins, cysteine proteases and proteasomes 49 . In contrast, a recent study suggested that the broad spectrum calpain and cysteine protease inhibitor E64 are not able to prevent the miltefosine induced DNA fragmentation. Whereas broad spectrum caspase inhibitor Z-VAD-FMK and Boc-D-FMK prevent the miltefosine induced DNA fragmentation, but have no preventive effect on externalization of phosphatidyl serine 31 . Although the involvements of other cysteine proteases and caspase like activities are reported in PCD of Leishmania 40 , caspase independent cell death pathways are also recognized 50 .
We observed higher level of gene expression of MAP2 under apoptotic condition, suggesting the importance of MAP2 protease in PCD of parasite 20 . In the present study, we examined the biochemical effect of TNP-470, a well known MAP2 inhibitor, on the miltefosine induced PCD of parasite. While control Leishmania promastigote cells treated with miltefosine showed all characteristics features of apoptosis whereas the Leishmania cells treated with both miltefosine and TNP-470 did not show the increased caspase3/7 protease like activity and several other characteristics features of apoptosis. Furthermore, the cell lysates of miltefosine induced promastigotes after pre-incubation with TNP-470, showed the decrease in caspase3/7 protease like activity. It is evident from confocal microscopy data that TNP-470 protects the leishmanial cells from miltefosine induced membrane depolarization as well as increase in the global pool of cytosolic calcium. Further, TNP-470 inhibits the oligonucleosomal DNA fragmentation in miltefosine induced cells. These data together suggests the involvement of MAP2 in PCD of leishmanial cells.
However, TNP-470 treatment of L. donovani promastigotes does not inhibit the phosphatidyl serine externalization induced by miltefosine and prevent the cell death. Although, MAP2 inhibition can inhibit induction of apoptosis of parasite under standard apoptotic condition (miltefosine treatment), the MAP2 inhibition is also not favorable for parasite survival as it is also involved in several other key functions. It is worth mentioning that in eukaryotes, MAP2 also plays a significant role in carrying out the regulation of protein synthesis and post translational modifications by removing the N-terminal methionine residue from the nascent peptide and by protection In conclusion, our findings provided the first evidence, to our knowledge that the treatment of L. donovani with TNP-470, a well-known MAP2 inhibitor prevented the induction of apoptosis in miltefosine induced promastigotes, but was not able to prevent cell death of the parasites. Based on these observations, our studies suggest the role of MAP2 in L. donovani, as an effector molecule in higher eukaryotes which is important for the induction of apoptosis but unable to prevent the cell death. The role of MAP2 in Leishmania parasite deserves more attention to understand its role in apoptosis like cell death. Furthermore, studies on mechanism of action of TNP-470 and proteomic analysis may provide the detailed answer. Refolding and western blot analysis of LdMAP2. The dialyzed recombinant protein was subjected to refolding. Refolding of Ni-NTA purified LdMAP2 was optimized by testing various buffer conditions with some modifications 53 . The protein was diluted ten times (50 μg protein/ml refolding buffer) followed by drop wise addition of protein in refolding buffer (20 mM Tris-HCl, 300 mM arginine, 20 mM cysteine, 150 mM NaCl, 5% (v/v) glycerol, pH 7.5) at 4 °C. Western blot analysis of purified LdMAP2 was done with antibodies against mouse anti-His (1:1000), and further treated with anti-mouse horse radish peroxidase conjugated secondary antibodies (1:1000). The membrane was further subjected to 3,3′-Diaminobenzidine (DAB) and 1% H 2 O 2 for immunodetection 54 .
Methods

Parasites
Determination of LdMAP2 enzyme activity. The fluorogenic substrate L-Methionine 7-amido-4-methylcoumarin (Met-AMC) was used for enzymatic assay. The LdMAP2 enzymatic activity was determined by measuring the release of 7-AMC by fluorescence (λ Ex = 360 nm and λ Em = 440 nm) 55, 56 . LdMAP2 enzymatic assay was carried out at 37 °C with 1 ml reaction volume containing 50 mM Tris-HCl pH 7.5, 5 mM NiSO 4 , 10 µM-150 µM Met-AMC and 15 µg recombinant LdMAP2. The release of 7-AMC was measured after 2 h incubation at 37 °C. The Km (Michaelis constant) was determined by an end point assay.
For optimum pH analysis, the buffer systems used were 50 mM Sodium acetate for pH 4.0 to 5.5, 50 mM Sodium phosphate buffer for pH 6.0-6.5 and 50 mM Tris-HCl buffer for pH 7.0-11.0. 5 mM NiSO 4 was also added in each buffer system. For optimum temperature studies different sets of temperature (20 °C-60 °C) were used. Since L. donovani MAP2 is a metalloprotease and its crystal structure complexed with metal ion has not been reported, we have evaluated the activity of L. donovani MAP2 with various divalent metal ions. To measure the effect of divalent metal ions on LdMAP2 activity; NiSO 4 , NiCl 2 , CuCl 2 , CaCl 2 , MgCl 2 , ZnCl 2 , MnCl 2 and EDTA were added at a final concentration of 5 mM in assay mixture.
LdMAP2 inhibition studies. The known inhibitor of MAP2, TNP-470 was assessed against the recombinant LdMAP2. Single point inhibition assay was carried out in 1 ml reaction volume containing 100 µM inhibitor TNP-470, pre-incubated in 50 mM Tris-HCl buffer pH 7.5, 5 mM NiSO 4 for 30 min. Varying concentration of substrate Met-AMC and 15 µg recombinant LdMAP2 was added in pre-incubated reaction mixture and further incubated at 37 °C for 2 h. The data were plotted in double-reciprocal plot to examine the mode of inhibition and to calculate the inhibitory constant (K i ). Determination of caspase-3/7 protease like activity. Intracellular caspase-3/7 protease like activity in L. donovani promastigote cells was measured fluorometrically using Apo-1 homogenous caspase 3/7 activity assay kit (Promega). The assays were performed according to manufacturer's instructions and as reported Scientific RepoRts | 7: 95 | DOI:10.1038/s41598-017-00186-9 earlier 4 . Briefly, 1 × 10 6 promastigote cells were treated with 20 µM of TNP-470 in presence and absence of miltefosine (25 µM) and incubated for 18 h at 25 °C. 0.2% DMSO treated promastigotes were taken as negative control, whereas 25 µM of miltefosine treated cells were used as a positive control. The release of R110 was measured by fluorescence at an excitation and emission wavelengths of 485 nm and 530 nm, respectively. In parallel set of reactions, caspase3/7 inhibitor was added in reaction mixture prior to the addition of treated cells. DNA fragmentation Assay by agarose gel electrophoresis. DNA fragmentation was analyzed by agarose gel electrophoresis of total genomic DNA, which was isolated as reported earlier with minor modifications 4, 52 . Briefly, cell pellets of 1 × 10 8 promastigotes were lysed in 500 µl of lysis buffer (50 mM Tris-HCl, 10 mM EDTA, 0.5% SDS; pH 7.5) containing proteinase K (100 µg/ml), vortexed and kept overnight to digest at 50 °C. RNase A (0.3 mg/ml) was added and then incubated at 37 °C for 1 h. The lysates were extracted using phenol-chloroform-isoamyalcohol (25:24:1) and centrifuged at 15000 × g for 10 min. The upper aqueous phase was collected, treated with 1/10 th volume of 3 M sodium acetate and 2 volume of 100% ethanol overnight at −20 °C. The sample was centrifuged at 15000 × g for 15 min and washed with 500 µl of 70% ethanol. The DNA pellet was dissolved in TE buffer (10 mM Tris-HCl, 1 mM EDTA; pH 8.0) and quantified spectrophotometrically at 260/280 nm. A total of 10 µg of genomic DNA was run on 1.5% agarose gel containing ethidium bromide for 2 h at 50 V and visualized under UV illuminator (Bio-Rad).
In vitro
Flow cytometric analysis of DNA content. Flow cytometric analysis of DNA content was done by the methods described in our earlier publications with minor modifications 4 . In brief, 2 × 10 7 L. donovani promastigote cells were treated with 20 µM of TNP-470 in presence or absence of miltefosine (25 µM) for 12 hrs at 25 °C. Cells were then centrifuged at 1000 × g for 5 min and washed twice with cold PBS to remove the traces of media, fixed in pre chilled 70% methanol (added drop wise) and incubated overnight at −20 °C. The fixed cells were centrifuged at 3000 × g, washed twice with cold PBS and then treated with RNase A (200 µg/ml) and incubated at 37 °C for 30 min. Cells were then treated with 20 µg/ml of PI (propidium iodide), incubated at room temperature for 30 min in the dark and acquired by CytoFLEX Flow Cytometer-Beckman Coulter, Inc. The percentage of hypodiploidy was calculated by CytExpert software. The value of Gain for FSC-A was 120 and for SSC-A was 100; Threshold was set to default (automatic); Channel ECD was used for width. ECD-H vs. ECD -A was plotted using SSC vs. FSC data and gate was fixed for all the experiments. ECD-w vs. ECD-A was plotted for gated cells and total number of cells (count) vs. ECD-A was plotted for analysis.
Laser Scanning Confocal Microscopy analysis to check the transmembrane potential of mitochondria (ΔΨm). ΔΨm was estimated by using the MitoCapture ™ apoptosis detection kit (Calbiochem) according to the earlier reports 35 . Briefly, 1 × 10 7 promastigote cells after different treatments were centrifuged at 1000 × g for 5 min, washed twice by PBS and resuspended in 1 ml incubation buffer containing MitoCapture ™ dye. The cells were incubated for 30 min at 37 °C, washed twice and resuspended into 500 µl of incubation buffer. Stained promastigotes were mounted on a glass slide and were observed by Leica DMi8 Confocal Microscopy under magnification of 63x (1.4 NA). The fluorescence signal was observed sequentially, exciting first at 488 nm (Ar-Kr laser beam) and then at 543 nm (He-Ne laser beam). The green fluorescence was measured at 488 nm excitation and red fluorescence was monitored at 543 nm.
Detection of phosphatidyl serine exposure on plasmamembrane. Analysis of phosphatidyl serine
exposure on plasma membrane of promastigote cells was done by using Annexin-V-FITC apoptosis detection kit (Calbiochem) according to our earlier publications 35, 59 . Briefly, 1 × 10 6 untreated or treated cells were centrifuged at 1000 x g for 5 min, washed twice with cold PBS and stained with Annexin-V-FITC and PI as per manufacturer's instructions with minor modifications. The fluorescence intensity was detected by FACSCalibur flow cytometer (Becton Dickinson) and analyzed by CellQuest software.
Measurement of intracellular Ca 2+ concentrations.
Changes in intracellular Ca 2+ concentrations were estimated by fluorescent probe, FURA 2AM as described earlier 35 . Cells were treated with TNP-470 and miltefosine as mentioned in above section. Fluorescence intensity was measured at an excitation and emission wavelength of 340 nm and 510 nm, respectively.
